Genomics

Dataset Information

0

Smyd5 mediates IL-4 epigenetic control of macrophage antigen presentation to drive cooperative T cell-mediated tumor suppression [ATAC-seq]


ABSTRACT: IL-4 is classically associated with “M2” macrophages considered tumor-immunosuppressive, yet marker-based labels poorly reflect macrophage function in tumors. Reports of a non-canonical, IL-4–imprinted macrophage state (M2inf) with trained-immunity features prompted us to test whether such imprinting contributes to antitumor immunity in vivo. Here we show that, in B16F10 melanoma, IL-4 programs macrophages through the lysine methyltransferase Smyd5 to deposit promoter-proximal H3K36me3, increase MHC class II, and potentiate T cell activation. Myeloid Il4ra deletion increased tumor burden and reduced MHC class II and intratumoral T cell activation, whereas co-transfer of IL-4–primed macrophages suppressed tumors and expanded activated CD4 and CD8 T cells. Antitumor benefit required adaptive lymphocytes and macrophage-intrinsic MHC class II, as Rag1 deficiency or macrophage Rfx5 deletion abrogated tumor suppression. These findings identify a non-canonical, IL-4–imprinted macrophage program that enables antigen presentation and cooperative T cell immunity in this tumor context.

ORGANISM(S): Mus musculus

PROVIDER: GSE315253 | GEO | 2026/01/26

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2026-01-26 | GSE315363 | GEO
2026-01-26 | GSE315361 | GEO
2026-01-26 | GSE315255 | GEO
2022-08-08 | E-MTAB-11799 | biostudies-arrayexpress
2022-10-02 | GSE189772 | GEO
2022-10-02 | GSE189769 | GEO
2022-10-02 | GSE189767 | GEO
2022-10-02 | GSE189771 | GEO
2024-05-22 | PXD049188 | Pride
2024-08-10 | PXD051695 | Pride